During the last session, Cabaletta Bio Inc (NASDAQ:CABA)’s traded shares were 1.43 million, with the beta value of the company hitting 2.42. At the end of the trading day, the stock’s price was $16.11, reflecting an intraday loss of -2.01% or -$0.33. The 52-week high for the CABA share is $26.35, that puts it down -63.56 from that peak though still a striking 53.88% gain since the share price plummeted to a 52-week low of $7.43. The company’s market capitalization is $690.31M, and the average intraday trading volume over the past 10 days was 1.02 million shares, and the average trade volume was 926.99K shares over the past three months.
Cabaletta Bio Inc (NASDAQ:CABA) trade information
Cabaletta Bio Inc (CABA) registered a -2.01% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.01% in intraday trading to $16.11, hitting a weekly high. The stock’s 5-day price performance is -6.06%, and it has moved by -25.69% in 30 days. Based on these gigs, the overall price performance for the year is 90.65%. The short interest in Cabaletta Bio Inc (NASDAQ:CABA) is 7.09 million shares and it means that shorts have 8.1 day(s) to cover.
Cabaletta Bio Inc (CABA) estimates and forecasts
Statistics show that Cabaletta Bio Inc has underperformed its competitors in share price, compared to the industry in which it operates. Cabaletta Bio Inc (CABA) shares have gone up 8.85% during the last six months, with a year-to-date growth rate less than the industry average at -10.30% against 13.70. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to shrink -6.70% this quarter and then drop -27.00% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -26.63%. While earnings are projected to return -15.09% in 2024.
CABA Dividends
Cabaletta Bio Inc is due to release its next quarterly earnings between May 09 and May 13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Cabaletta Bio Inc (NASDAQ:CABA)’s Major holders
Cabaletta Bio Inc insiders own 3.14% of total outstanding shares while institutional holders control 101.54%, with the float percentage being 104.83%. Fred Alger Management, LLC is the largest shareholder of the company, while 188 institutions own stock in it. As of Jun 29, 2023, the company held over 4.57 million shares (or 11.49% of all shares), a total value of $59.04 million in shares.
The next largest institutional holding, with 3.27 million shares, is of Adage Capital Partners GP L.L.C.’s that is approximately 8.21% of outstanding shares. At the market price on Jun 29, 2023, these shares were valued at $42.17 million.
Also, the Mutual Funds coming in first place with the largest holdings of Cabaletta Bio Inc (CABA) shares are Alger Small Cap Focus Fund and Vanguard Total Stock Market Index Fund. Data provided on Jul 30, 2023 indicates that Alger Small Cap Focus Fund owns about 3.22 million shares. This amounts to just over 8.09 percent of the company’s overall shares, with a $43.87 million market value. The same data shows that the other fund manager holds slightly less at 1.14 million, or about 2.87% of the stock, which is worth about $14.75 million.
